Döhner, Hartmut
Dolnik, Anna
Tang, Lin
Seymour, John F.
Minden, Mark D.
Stone, Richard M.
del Castillo, Teresa Bernal
Al-Ali, Haifa Kathrin
Santini, Valeria
Vyas, Paresh http://orcid.org/0000-0003-3931-0914
Beach, C. L.
MacBeth, Kyle J.
Skikne, Barry S.
Songer, Steve
Tu, Nora
Bullinger, Lars
Dombret, Hervé
Funding for this research was provided by:
This study was funded by Celgene Corporation.
Article History
Received: 28 May 2018
Revised: 24 July 2018
Accepted: 6 August 2018
First Online: 1 October 2018
Compliance with ethical standards
:
: H. Döhner: Advisory Boards (with honoraria): AbbVie, Agios, Amgen, Astellas, Astex Pharmaceuticals, Celator, Celgene Corporation, Janssen, Jazz Pharmaceuticals, Novartis, Seattle Genetics, Sunesis. J.F.S.: Advisory Committees, AbbVie, Celgene Corporation, Genentech, Gilead, Janssen, Roche, Takeda; Consultancy, AbbVie, Celgene Corporation, Genentech, Gilead, Janssen, Roche, Takeda; Honoraria, AbbVie, Celgene Corporation, Genentech, Gilead, Janssen, Roche, Takeda; Travel support, AbbVie, Celgene Corporation; Research Funding, AbbVie, Janssen; Speakers Bureau, AbbVie, Celgene Corporation, Gilead, Janssen, Roche. R.M.S.: Consultancy, AbbVie, Agios, Amgen, BristolMeyersSquibb, Celator, Celgene Corporation, Janssen, Juno Therapeutics, Karyopharm, Merck, Novartis, Roche/Genentech, Pfizer, Seattle Genetics, Sunesis Pharmaceuticals, Xenetic Biosciences; Research Funding, Agios, Celator, Karyopharm, Novartis, Pfizer; Advisory Committees, Celgene Corporation. H.K.A.-A.: Consultancy, Honoraria and Research Funding, Celgene; Consultancy, Honoraria and Research Funding, Novartis. V.S.: Consultancy, Amgen, Astex, Celgene Corporation, Janssen, Novartis, Onconova; Honoraria, Celgene Corporation, Janssen, Novartis; Research Funding, Celgene Corporation. P.V.: Honoraria and Research Funding, Celgene Corporation. S.S., C.L.B., L.T., K.J.M., B.S.S.: Employment and equity ownership, Celgene Corporation. L.B.: Advisory Committees BristolMeyersSquibb, Boehringer Ingelheim, Celgene Corporation, Jazz Pharmaceuticals, Novartis, MSD Sharp & Dohme GmbH, Merck, Seattle Genetics. The remaining authors declare that they have no conflict of interest.